As a highly-motivated and application-orientated researcher, Dr. Natalia Bourguignon has proven track record working in interdisciplinary areas. She received a Bachelor in Biotechnology (2010) and her Ph.D. degree (2016) from the National University of Tucumán, Argentina. The objective of her Ph.D. work was the physiological and molecular study of polycyclic aromatic hydrocarbons bioremediation by actinobacteria. After completion of her Ph.D., she started working in the field of microfluidics with different biological applications at the National Technological University, Argentina. Then, she joined Dr. Shekhar Bhansali’s Bio-MEMS and Microsystems Research Group at the Department of Electrical and Computer Engineering. Her major work involved the development of “Lab on a Chip” microfluidic technologies for the production of biotherapeutics, applications in drug screening, and toxicity assessment. She participated in the NSF-awarded I-Corps program (2020) to develop entrepreneurial skills, research feasibility and learn the basics of commercialization, customer, and market of a microbioreactor for the manufacture of affordable biopharmaceuticals. In the RCMI-FIU project, her translational objective is to develop a new microfluidic device that will provide a fast, reproducible, and low-cost approach to improve the treatment of people infected with Trypanosoma cruzi, decreasing health disparities in Chagas disease.